Dr. Kieran Chacko Co-Founder & Head of Data Science, Harbinger Health

Kieran is a Principal at Flagship Pioneering where he works as part of a venture creation team to create and grow breakthrough biotechnology companies. He is a member of the founding team of Flagship-founded Harbinger Health responsible for driving all aspects of company operations, strategy, and growth. Kieran currently serves as the Head of Strategy and Data Science at Harbinger, driving fundraising, business development, and computational science research to uncover novel biological insights that underpin the origins of cancer as the foundation for new diagnostics and therapeutics. Prior to joining Flagship and completing his graduate studies, Kieran worked in the Corporate and Investment Bank at J.P. Morgan Chase & Co in New York City. He was part of teams across the markets and securities business serving the firm’s large corporate financial institution and emerging market clients. Kieran holds a doctorate in Computational Biology from the Icahn Institute for Genetics and Genomic Sciences, in addition to a B.A. in Economics and a B.S. in Biochemistry from the University of Rochester. He is the recipient of multiple awards from the American Society of Microbiology, Infectious Disease Society of America, and Mount Sinai Hospital for his research.